{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:23:50Z","timestamp":1790515430967,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.psychres.2010.04.008","type":"journal-article","created":{"date-parts":[[2010,5,18]],"date-time":"2010-05-18T03:20:15Z","timestamp":1274152815000},"page":"24-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Plasma homocysteine in schizophrenia: Determinants and clinical correlations in Tunisian patients free from antipsychotics"],"prefix":"10.1016","volume":"179","author":[{"given":"Noomen","family":"Bouaziz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imen","family":"Ayedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oussama","family":"Sidhom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameni","family":"Kallel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rym","family":"Rafrafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riadh","family":"Jomaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wahid","family":"Melki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moncef","family":"Feki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naziha","family":"Kaabechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zouhaier","family":"El Hechmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2010.04.008_bib1","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.euroneuro.2006.03.006","article-title":"Homocysteine levels in adolescent schizophrenia patients","volume":"16","author":"Adler Nevo","year":"2006","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2010.04.008_bib2","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.clinbiochem.2007.06.001","article-title":"Associations of blood homocysteine concentrations in Arab schizophrenic patients","volume":"40","author":"Akanji","year":"2007","journal-title":"Clinical Biochemistry"},{"key":"10.1016\/j.psychres.2010.04.008_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-244X-7-15","article-title":"Is dietary pattern of schizophrenia patients different from healthy subjects?","volume":"7","author":"Amani","year":"2007","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.psychres.2010.04.008_bib4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jpsychires.2004.01.003","article-title":"Homocysteine levels in newly admitted schizophrenic patients","volume":"38","author":"Applebaum","year":"2004","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.psychres.2010.04.008_bib5","series-title":"Homocysteine, Related Vitamins and Neuropsychiatric Disorders","author":"Bolander-Gouaille","year":"2003"},{"key":"10.1016\/j.psychres.2010.04.008_bib6","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.pnpbp.2005.06.028","article-title":"Homocysteine and schizophrenia: from prenatal to adult life","volume":"29","author":"Brown","year":"2005","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.psychres.2010.04.008_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/archpsyc.64.1.31","article-title":"Elevated prenatal homocysteine levels as a risk factor for schizophrenia","volume":"64","author":"Brown","year":"2007","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2010.04.008_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1076\/neur.9.2.97.15075","article-title":"Can specific deficits in executive functioning explain the negative symptoms of schizophrenia? A review","volume":"9","author":"Donohoe","year":"2003","journal-title":"Neurocase"},{"key":"10.1016\/j.psychres.2010.04.008_bib9","first-page":"319","article-title":"Pharmacokinetic studies on haloperidol in man","volume":"20","author":"Forsman","year":"1976","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"key":"10.1016\/j.psychres.2010.04.008_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","article-title":"A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase","volume":"10","author":"Frosst","year":"1995","journal-title":"Nature Genetics"},{"key":"10.1016\/j.psychres.2010.04.008_bib11","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1176\/appi.ajp.161.9.1705","article-title":"Folate, homocysteine, and negative symptoms in schizophrenia","volume":"16","author":"Goff","year":"2004","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2010.04.008_bib12","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.pnpbp.2007.05.011","article-title":"Plasma homocysteine, folate and B12 in chronic schizophrenia","volume":"3","author":"Haidemenos","year":"2007","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.psychres.2010.04.008_bib13","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/ajcn\/73.3.613","article-title":"Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort","volume":"73","author":"Jacques","year":"2001","journal-title":"The American Journal of Clinical Nutrition"},{"key":"10.1016\/j.psychres.2010.04.008_bib14","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0006-3223(00)00988-4","article-title":"Cortical bcl-2 protein expression and apoptotic regulation in schizophrenia","volume":"48","author":"Jarskog","year":"2000","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2010.04.008_bib15","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.molmed.2009.10.001","article-title":"One-carbon metabolism and schizophrenia: current challenges and future directions","volume":"15","author":"Krebs","year":"2009","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/j.psychres.2010.04.008_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2125.1978.tb01619.x","article-title":"The effects of chronic drug administration on hepatic enzyme induction and folate metabolism","volume":"5","author":"Labadarios","year":"1978","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.psychres.2010.04.008_bib17","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/01.wnr.0000215777.99473.52","article-title":"Serum homocysteine, folate level and methylenetetrahydrofolate reductase 677, 1298 gene polymorphism in Korean schizophrenic patients","volume":"17","author":"Lee","year":"2006","journal-title":"Neuroreport"},{"key":"10.1016\/j.psychres.2010.04.008_bib18","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.4088\/JCP.v66n1210","article-title":"High serum homocysteine levels in young male schizophrenic and schizoaffective patients with tardive Parkinsonism and\/or tardive dyskinesia","volume":"66","author":"Lerner","year":"2005","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2010.04.008_bib19","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1176\/appi.ajp.159.10.1790","article-title":"Elevated homocysteine levels in young male patients with schizophrenia","volume":"159","author":"Levine","year":"2002","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2010.04.008_bib20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.biopsych.2005.10.009","article-title":"Homocysteine-reducing strategies improve symptoms in chronic schizophrenic patients with hyperhomocysteinemia","volume":"60","author":"Levine","year":"2006","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2010.04.008_bib21","series-title":"Histocompatibility testing","first-page":"587","article-title":"Standardized Southern blot workshop techniques","author":"Marcadet","year":"1987"},{"key":"10.1016\/j.psychres.2010.04.008_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0166-2236(03)00032-8","article-title":"Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders","volume":"26","author":"Mattson","year":"2003","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.psychres.2010.04.008_bib23","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.cub.2005.11.059","article-title":"Schizophrenia","volume":"15","author":"Morrison","year":"2005","journal-title":"Current Biology"},{"key":"10.1016\/j.psychres.2010.04.008_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-1781(03)00200-2","article-title":"Homocysteine metabolism and B-vitamins in schizophrenic patients: low plasma folate as a possible independent risk factor for schizophrenia","volume":"121","author":"Muntjewerff","year":"2003","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.psychres.2010.04.008_bib26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ajmg.b.30179","article-title":"Hyperhomocysteinemia, methylenetetrahydrofolate reductase 677TT genotype, and the risk for schizophrenia: a Dutch population based case-control study","volume":"135","author":"Muntjewerff","year":"2005","journal-title":"American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : The Official Publication of the International Society of Psychiatric Genetics"},{"key":"10.1016\/j.psychres.2010.04.008_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.mp.4001746","article-title":"Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis","volume":"11","author":"Muntjewerff","year":"2006","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.psychres.2010.04.008_bib28","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1176\/appi.ajp.162.9.1738","article-title":"Relation of plasma glycine, serine, and homocysteine levels to schizophrenia symptoms and medication type","volume":"162","author":"Neeman","year":"2005","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2010.04.008_bib29","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/archpsyc.1997.01830220079011","article-title":"Delayed normalization of central D2 dopamine receptor availability after discontinuation of haloperidol decanoate. Preliminary findings","volume":"54","author":"Nyberg","year":"1997","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2010.04.008_bib30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.ypg.0000242192.28526.fa","article-title":"No association of the C677T methylenetetrahydrofolate reductase polymorphism with schizophrenia","volume":"16","author":"Philibert","year":"2006","journal-title":"Psychiatric Genetics"},{"key":"10.1016\/j.psychres.2010.04.008_bib31","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.pnpbp.2005.06.023","article-title":"Schizophrenia and single-carbon metabolism","volume":"29","author":"Regland","year":"2005","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.psychres.2010.04.008_bib32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01271539","article-title":"Homocysteinemia is a common feature of schizophrenia","volume":"100","author":"Regland","year":"1995","journal-title":"Journal of Neural Transmission. General Section"},{"key":"10.1016\/j.psychres.2010.04.008_bib33","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00702-003-0061-3","article-title":"Homocysteinemia in psychiatric disorders: association with dementia and depression, but not schizophrenia in female patients","volume":"110","author":"Reif","year":"2003","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/j.psychres.2010.04.008_bib34","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.biopsych.2006.12.017","article-title":"Contribution of methylene tetrahydrofolate reductase (MTHFR) polymorphisms to negative symptoms in schizophrenia","volume":"1","author":"Roffman","year":"2008","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2010.04.008_bib35","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.pnpbp.2005.06.026","article-title":"Homocysteine and brain atrophy","volume":"29","author":"Sachdev","year":"2005","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.psychres.2010.04.008_bib36","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1017\/S1368980007668578","article-title":"Mediterranean diet and depression","volume":"9","author":"Sanchez-Villegas","year":"2006","journal-title":"Public Health Nutrition"},{"key":"10.1016\/j.psychres.2010.04.008_bib37","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0169-328X(03)00327-9","article-title":"Methylenete trahydrofolate reductase gene polymorphisms in patients with schizophrenia","volume":"17","author":"Sazci","year":"2003","journal-title":"Brain Research. Molecular Brain Research"},{"key":"10.1016\/j.psychres.2010.04.008_bib38","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.pnpbp.2005.06.022","article-title":"Association of the C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene with schizophrenia: association is significant in men but not in women","volume":"29","author":"Sazci","year":"2005","journal-title":"Progress in Neuropsychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.psychres.2010.04.008_bib39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1124\/jpet.102.047092","article-title":"L-homocysteine sulfinic acid and other acidichomocysteine derivatives are potent and selective metabotropic glutamate receptor agonists","volume":"305","author":"Shi","year":"2003","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.psychres.2010.04.008_bib40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0920-9964(97)00005-4","article-title":"Oxidative reactions and schizophrenia: a review-discussion","volume":"24","author":"Smythies","year":"1997","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2010.04.008_bib41","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0006-3223(97)00427-7","article-title":"Schizophrenia and impaired homocysteine metabolism: a possible association","volume":"44","author":"Susser","year":"1998","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2010.04.008_bib42","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.pnpbp.2005.06.025","article-title":"The central nervous system in animal models of hyperhomocysteinemia","volume":"29","author":"Troen","year":"2005","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.psychres.2010.04.008_bib43","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/ajcn\/82.3.627","article-title":"High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study","volume":"82","author":"Tucker","year":"2005","journal-title":"The American Journal of Clinical Nutrition"},{"key":"10.1016\/j.psychres.2010.04.008_bib44","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.pnpbp.2005.07.001","article-title":"Further evidence that hyperhomocysteinemia and methylene tetrahydrofolate reductase C677T and A1289C polymorphisms are not risk factors for schizophrenia","volume":"29","author":"Vilella","year":"2005","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.psychres.2010.04.008_bib45","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1097\/00001756-199907130-00008","article-title":"Plasma homocysteine and the methylenetetrahydrofolate reductase C677T gene variant: lack of association with schizophrenia","volume":"10","author":"Virgos","year":"1999","journal-title":"Neuroreport"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178110001678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178110001678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:19:57Z","timestamp":1759036797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178110001678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0165178110001678"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2010.04.008","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma homocysteine in schizophrenia: Determinants and clinical correlations in Tunisian patients free from antipsychotics","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2010.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}